SCHEMBL24330220

SCHEMBL24330220

COC(=O)c1ccc2nc(CN3CCC(c4cccc(OC)n4)CC3)n(C[C@@H]3CCO3)c2c1

nearest known ligand 0.64

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 20/20 0.64
▸ CYP2C8 P10632 2/20 0.60
▸ KCNH2 Q12809 2/20 0.60
▸ HTR1A P08908 1/20 0.60
▸ HTR2A P28223 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24338370 0.93 GLP1R (0.73) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL24338085 0.92 GLP1R (0.61) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL25955101 0.92 GLP1R (0.63) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL26490429 0.92 GLP1R (0.58) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL29574129 0.91 GLP1R (0.59) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL30151557 0.91 GLP1R (0.59) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL24330242 0.91 GLP1R (0.59) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL29974969 0.91 GLP1R (0.59) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL24265545 0.91 GLP1R (0.59) GLP1RCYP2C8KCNH2HTR1AHTR2A
SCHEMBL30903419 0.90 GLP1R (0.60) GLP1RCYP2C8KCNH2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4227299-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. (CN) 2023-08-16 — — EP disclosed
WO-2022078152-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF 杭州中美华东制药有限公司 2022-04-21 — — WO disclosed
WO-2022068772-A1 BENZIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 深圳信立泰药业股份有限公司 2022-04-07 — — WO disclosed
Send feedback